Who owns the NSI technology?
NSI has licensed the technology for the purpose of commercial development from the University of Louisville.
How much research has been conducted on this technology?
The earliest research by Dr. Casanova dates back more than a decade, and more recent research on the detection technology dates back 10 years.
What is gyrification, and what does it measure?
The surface of the brain, referred to as the cerebral cortex, is very uneven and is characterized by a distinctive pattern of folds or bumps, known as gyri (singular: gyrus), and grooves, known as sulci (singular: sulcus). These gyri and sulci form important landmarks that allow separating the brain into functional centers.
Where is the NSI technology currently being used?
The research studies at the University of Louisville have been concluded, and NSI is currently conducting a “ground true” evaluation of the technology in preparation for submission to the FDA.
How early can “The Technology” identify autism?
Our Technology has demonstrated in research studies to uncover autism in children as young as toddlers.
How accurate is “The Technology” at detecting autism?
A research version of the algorithm achieved an autism identification rate of 94%.
How do you use “The Technology”?
Our software automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from a set of MR images.
How does “The Technology” work?
Using images from MRI scans, our software measures predetermined brain regions for specific surface characteristics that have been shown to correlate to autism. Then, it classifies the brain based on these measurements.
How long does “The Technology” take to produce results?
Once an MRI image file is received, the analysis and resulting report is completed within a few hours.
What other applications might “The Technology” have?
In the future, NSI plans to investigate the Technology’s potential to assist clinicians in identifying other neurological conditions, such as ADHD, dyslexia, schizophrenia, and Alzheimer’s.
